Publication date: Jul 01, 2025
Cellular Indexing of Transcriptomes and Epitopes by Sequencing (CITE-seq) enables paired measurement of surface protein and mRNA expression in single cells using antibodies conjugated to oligonucleotide tags. Due to the high copy number of surface protein molecules, sequencing antibody-derived tags (ADTs) allows for robust protein detection, improving cell-type identification. However, variability in antibody staining leads to batch effects in the ADT expression, obscuring biological variation, reducing interpretability, and obstructing cross-study analyses. Here, we present ADTnorm, a normalization and integration method designed explicitly for ADT abundance. Benchmarking against 14 existing scaling and normalization methods, we show that ADTnorm accurately aligns populations with negative- and positive-expression of surface protein markers across 13 public datasets, effectively removing technical variation across batches and improving cell-type separation. ADTnorm enables efficient integration of public CITE-seq datasets, each with unique experimental designs, paving the way for atlas-level analyses. Beyond normalization, ADTnorm includes built-in utilities to aid in automated threshold-gating as well as assessment of antibody staining quality for titration optimization and antibody panel selection. Applying ADTnorm to an antibody titration study, a published COVID-19 CITE-seq dataset, and a human hematopoietic progenitors study allowed for identifying previously undetected phenotype-associated markers, illustrating a broad utility in biological applications.
Open Access PDF
Semantics
| Type | Source | Name |
|---|---|---|
| disease | IDO | cell |
| disease | IDO | protein |
| disease | IDO | quality |
| disease | MESH | COVID-19 |
| drug | DRUGBANK | Ferrous sulfate anhydrous |
| disease | MESH | aids |
| drug | DRUGBANK | Coenzyme M |
| drug | DRUGBANK | Cycloserine |
| drug | DRUGBANK | Hyaluronic acid |
| disease | IDO | process |
| drug | DRUGBANK | Esomeprazole |
| disease | MESH | anomalies |
| disease | IDO | blood |
| disease | MESH | autoimmunity |
| drug | DRUGBANK | L-Leucine |
| drug | DRUGBANK | Iron |
| drug | DRUGBANK | Tretamine |
| drug | DRUGBANK | Abacavir |
| drug | DRUGBANK | Pidolic Acid |
| drug | DRUGBANK | Gold |
| drug | DRUGBANK | Cysteamine |
| disease | MESH | leukemia |
| drug | DRUGBANK | Serine |
| disease | MESH | Arthritis |
| disease | MESH | Infection |
| disease | IDO | immunodeficiency |
| pathway | REACTOME | TCR signaling |
| drug | DRUGBANK | Rasagiline |
| pathway | REACTOME | Reproduction |